Showing results (121-130 of 162) with videos related to

Sort By:
Pageof 17
International Journal of Cancer|September 4, 1995
Low-dose IL-2 treatment: activation of discrete T- and NK-cell sub-populations in vivoF Farace, E Angevin, P Y Dietrich, et al.
International Journal of Cancer|July 17, 1997
In situ T-cell responses in a primary regressive melanoma and subsequent metastases: a comparative analysisG Carcelain, N Rouas-Freiss, E Zorn, et al.
Journal of Autoimmunity|August 1, 1988
T cells expressing gamma delta chain receptors in rheumatoid arthritisF M Brennan, M Londei, A M Jackson, et al.
International Journal of Cancer|June 11, 1997
T-cell receptor CDR3 size distribution analysis to evaluate specific T-cell response to cancer vaccinesF Farace, E Angevin, I Poullion, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 15, 1987
rIL 2-induced proliferation of human circulating NK cells and T lymphocytes: synergistic effects of IL 1 and IL 2M H Ben Aribia, E Leroy, O Lantz, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|October 1, 1995
Phase I study of prolonged low-dose subcutaneous recombinant interleukin-2 (IL-2) in patients with advanced cancerE Angevin, D Valteau-Couanet, F Farace, et al.
Science (New York, N.Y.)|June 28, 1985
Analysis of T-cell receptor gene rearrangement and expression in human natural killer clonesJ Ritz, T J Campen, R E Schmidt, et al.
Pageof 17